Sulin Wu

ORCID: 0000-0002-9820-724X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Diet and metabolism studies
  • Neuroendocrine Tumor Research Advances
  • Neutropenia and Cancer Infections
  • Gestational Trophoblastic Disease Studies
  • Protein Degradation and Inhibitors
  • Economic and Financial Impacts of Cancer
  • Intraperitoneal and Appendiceal Malignancies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Bone and Joint Diseases
  • PARP inhibition in cancer therapy

University of Chicago
2025

Center for Human Genetics
2022-2023

Case Western Reserve University
2022-2023

University Hospitals of Cleveland
2023

University School
2023

University Hospitals Seidman Cancer Center
2022

Purpose: Disparities in cancer care delivery remain a pressing health-care crisis within the United States (US). The use of immune checkpoint inhibitors (ICIs) and their management may be disparity generator that impacts survival. This retrospective study assessed disparities cohort patients with variety solid tumors treated ICIs single organization focusing on impact race, socioeconomic status (SES) site survival development severe immune-related adverse events (irAEs). Patients Methods:...

10.2147/cmar.s403569 article EN cc-by-nc Cancer Management and Research 2023-09-01
Coming Soon ...